Krsnaa Diagnostics Limited
Krsnaa Diagnostics Limited provides diagnostic services in India. It offers a range radiology services, including computed tomography scans, magnetic resonance imaging, X-rays, and ultrasound and advanced imaging; pathology services, such as laboratory, and home collection and preventive health; and teleradiology and telepathology services. The company also provides other diagnostics services, su… Read more
Krsnaa Diagnostics Limited (KRSNAA) - Total Assets
Latest total assets as of September 2025: ₹15.07 Billion INR
Based on the latest financial reports, Krsnaa Diagnostics Limited (KRSNAA) holds total assets worth ₹15.07 Billion INR as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Krsnaa Diagnostics Limited - Total Assets Trend (2017–2025)
This chart illustrates how Krsnaa Diagnostics Limited’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Krsnaa Diagnostics Limited - Asset Composition Analysis
Current Asset Composition (March 2025)
Krsnaa Diagnostics Limited's total assets of ₹15.07 Billion consist of 32.3% current assets and 67.7% non-current assets.
| Asset Category | Amount (INR) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | ₹0.00 | 0.3% |
| Accounts Receivable | ₹2.78 Billion | 21.7% |
| Inventory | ₹294.76 Million | 2.3% |
| Property, Plant & Equipment | ₹0.00 | 0.0% |
| Intangible Assets | ₹29.49 Million | 0.2% |
| Goodwill | ₹0.00 | 0.0% |
Asset Composition Trend (2017–2025)
This chart illustrates how Krsnaa Diagnostics Limited's asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Krsnaa Diagnostics Limited's current assets represent 32.3% of total assets in 2025, an increase from 17.2% in 2017.
- Cash Position: Cash and equivalents constituted 0.3% of total assets in 2025, down from 4.1% in 2017.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2017.
- Asset Diversification: The largest asset category is accounts receivable at 21.7% of total assets.
Krsnaa Diagnostics Limited Competitors by Total Assets
Key competitors of Krsnaa Diagnostics Limited based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
ADCNF
OTCGREY:ADCNF
|
USA | $4.51 Billion |
|
Berry Genomics Co Ltd
SHE:000710
|
China | CN¥2.34 Billion |
|
Malaysian Genomics Resource
KLSE:0155
|
Malaysia | RM20.70 Million |
|
NSN Co. Ltd
KQ:031860
|
Korea | ₩60.96 Billion |
|
JOONGANG DNM Co.Ltd
KQ:051980
|
Korea | ₩121.79 Billion |
|
GeneMatrix Inc
KQ:109820
|
Korea | ₩28.03 Billion |
|
Genoray Co. Ltd
KQ:122310
|
Korea | ₩125.67 Billion |
|
Green Cross Lab Cell Corporation
KQ:144510
|
Korea | ₩565.79 Billion |
Krsnaa Diagnostics Limited - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Moderate asset utilization - Krsnaa Diagnostics Limited generates 0.56x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Solid ROA - For every $100 in assets, Krsnaa Diagnostics Limited generates $6.06 in net profit.
Krsnaa Diagnostics Limited - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 1.42 | 1.09 | 1.18 |
| Quick Ratio | 1.34 | 1.01 | 1.15 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | ₹1.69 Billion | ₹ 361.78 Million | ₹ 328.32 Million |
Krsnaa Diagnostics Limited - Advanced Valuation Insights
This section examines the relationship between Krsnaa Diagnostics Limited's asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 2.35 |
| Latest Market Cap to Assets Ratio | 0.01 |
| Asset Growth Rate (YoY) | 9.4% |
| Total Assets | ₹12.82 Billion |
| Market Capitalization | $119.95 Million USD |
Valuation Analysis
Below Book Valuation: The market values Krsnaa Diagnostics Limited's assets below their book value (0.01 x), which may indicate investor concerns about asset quality or future growth.
Positive Asset Growth: Krsnaa Diagnostics Limited's assets grew by 9.4% over the past year, showing continued investment in the company's operational capacity.
Annual Total Assets for Krsnaa Diagnostics Limited (2017–2025)
The table below shows the annual total assets of Krsnaa Diagnostics Limited from 2017 to 2025.
| Year | Total Assets | Change |
|---|---|---|
| 2025-03-31 | ₹12.82 Billion | +9.36% |
| 2024-03-31 | ₹11.72 Billion | +28.80% |
| 2023-03-31 | ₹9.10 Billion | +3.85% |
| 2022-03-31 | ₹8.76 Billion | +44.93% |
| 2021-03-31 | ₹6.05 Billion | -4.04% |
| 2020-03-31 | ₹6.30 Billion | +19.09% |
| 2019-03-31 | ₹5.29 Billion | +79.74% |
| 2018-03-31 | ₹2.94 Billion | +67.58% |
| 2017-03-31 | ₹1.76 Billion | -- |